Form 4: Sarepta Therapeutics Executive Bilal Arif Reports Stock Disposals to Cover Tax Obligations
SEC Form 4 Filing
Bilal Arif, Chief Tech Ops Officer of Sarepta Therapeutics, reports the disposal of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Bilal Arif, Chief Tech Ops Officer at Sarepta Therapeutics, filed a Form 4 with the SEC.
- The filing reports the disposal of Sarepta Therapeutics common stock on March 4, 2024.
- A total of 285 shares were disposed of at a price of $125.32 per share to cover tax obligations.
- An additional 237 shares were disposed of at a price of $125.32 per share to cover tax obligations.
- Following the reported transactions, Arif directly owns 26,200 shares of Sarepta Therapeutics common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing indicates a routine transaction to cover tax obligations, which is neither particularly positive nor negative.
Industry Context
Executive stock transactions are a routine part of corporate governance and are closely watched by investors for insights into management's perspective on the company's value and future prospects. Disposals to cover tax obligations are common and generally not indicative of a negative outlook.
Key Dates
| Date | Description |
|---|---|
| 03/03/2021 | Date of grant for the restricted stock units related to the tax obligations. |
| 03/04/2024 | Date of stock disposal to cover tax obligations. |
| 03/06/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.